BIOMAT Database Logo BIOMAT Database Logo

Pulmonary artery thrombus in a premature neonate treated with recombinant tissue plasminogen activator. 2014

S D DeMeo, and A Sherwood, and C D Hornik, and R N Goldberg, and C M Cotten, and M Bidegain
Division of Neonatology, Duke University Medical Center, Durham, NC, USA.

Pulmonary artery thrombus is a rarely reported complication in premature neonates. The management of life-threatening thrombotic events in neonates is controversial, especially regarding the use of thrombolytics versus anticoagulation alone for treatment. We report a case of a premature neonate with symptomatic pulmonary artery thrombus treated with recombinant tissue plasminogen activator who survived without bleeding complications.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D008297 Male Males
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D015150 Echocardiography, Doppler Measurement of intracardiac blood flow using an M-mode and/or two-dimensional (2-D) echocardiogram while simultaneously recording the spectrum of the audible Doppler signal (e.g., velocity, direction, amplitude, intensity, timing) reflected from the moving column of red blood cells. Doppler Echocardiography,Echocardiography, Continuous Doppler,Echocardiography, Two-Dimensional Doppler,2-D Doppler Echocardiography,2D Doppler Echocardiography,Continuous Doppler Echocardiography,Doppler Echocardiography, 2-D,Doppler Echocardiography, 2D,Doppler Echocardiography, Continuous,Doppler Echocardiography, Two-Dimensional,Echocardiography, 2-D Doppler,Echocardiography, 2D Doppler,Two-Dimensional Doppler Echocardiography,2 D Doppler Echocardiography,Doppler Echocardiography, 2 D,Doppler Echocardiography, Two Dimensional,Echocardiography, 2 D Doppler,Echocardiography, Two Dimensional Doppler,Two Dimensional Doppler Echocardiography

Related Publications

S D DeMeo, and A Sherwood, and C D Hornik, and R N Goldberg, and C M Cotten, and M Bidegain
[Recombinant tissue plasminogen activator for thrombolytic therapy of right atrial thrombus in a neonate and infant].
May 1996, Pediatria polska,
S D DeMeo, and A Sherwood, and C D Hornik, and R N Goldberg, and C M Cotten, and M Bidegain
Lysis of a left ventricular thrombus with recombinant tissue plasminogen activator.
August 2001, Chest,
S D DeMeo, and A Sherwood, and C D Hornik, and R N Goldberg, and C M Cotten, and M Bidegain
Acute central retinal artery occlusion treated with intravenous recombinant tissue plasminogen activator.
November 2012, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
S D DeMeo, and A Sherwood, and C D Hornik, and R N Goldberg, and C M Cotten, and M Bidegain
Successful use of recombinant tissue plasminogen activator in the treatment of aortic thrombosis in a premature neonate.
May 1997, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,
S D DeMeo, and A Sherwood, and C D Hornik, and R N Goldberg, and C M Cotten, and M Bidegain
Massive pulmonary embolism: treatment with thrombus fragmentation and local fibrinolysis with recombinant human-tissue plasminogen activator.
January 1997, Cardiovascular and interventional radiology,
S D DeMeo, and A Sherwood, and C D Hornik, and R N Goldberg, and C M Cotten, and M Bidegain
Life-threatening pulmonary embolism with right-sided heart thrombus. Rapid recovery with recombinant tissue plasminogen activator.
April 1994, Chest,
S D DeMeo, and A Sherwood, and C D Hornik, and R N Goldberg, and C M Cotten, and M Bidegain
Subclavian vein thrombosis treated with recombinant tissue plasminogen activator.
January 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
S D DeMeo, and A Sherwood, and C D Hornik, and R N Goldberg, and C M Cotten, and M Bidegain
Expanding recombinant tissue plasminogen activator time window is premature.
November 2009, Stroke,
S D DeMeo, and A Sherwood, and C D Hornik, and R N Goldberg, and C M Cotten, and M Bidegain
Acute pulmonary embolism treated with tissue plasminogen activator.
October 1986, Lancet (London, England),
S D DeMeo, and A Sherwood, and C D Hornik, and R N Goldberg, and C M Cotten, and M Bidegain
A neonatal thrombosis patient treated successfully with recombinant tissue plasminogen activator.
September 2013, Turkish journal of haematology : official journal of Turkish Society of Haematology,
Copied contents to your clipboard!